Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone Deacetylase Inhibitors | 13 | 2018 | 777 | 2.670 |
Why?
|
| Hydroxamic Acids | 12 | 2018 | 483 | 2.510 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2025 | 521 | 1.310 |
Why?
|
| Sepsis | 9 | 2018 | 2606 | 1.060 |
Why?
|
| Histone Deacetylases | 4 | 2015 | 708 | 1.020 |
Why?
|
| Indoles | 6 | 2018 | 1839 | 1.010 |
Why?
|
| Shock, Septic | 5 | 2016 | 774 | 0.980 |
Why?
|
| Urethral Neoplasms | 1 | 2025 | 37 | 0.970 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2022 | 76 | 0.760 |
Why?
|
| Choristoma | 1 | 2023 | 206 | 0.760 |
Why?
|
| Pancreas | 2 | 2023 | 1700 | 0.620 |
Why?
|
| Brachytherapy | 2 | 2025 | 1222 | 0.610 |
Why?
|
| Cysts | 1 | 2023 | 684 | 0.590 |
Why?
|
| Ornithine | 2 | 2016 | 80 | 0.570 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2025 | 1761 | 0.550 |
Why?
|
| Traumatology | 1 | 2016 | 102 | 0.500 |
Why?
|
| Sirtuin 2 | 1 | 2015 | 93 | 0.460 |
Why?
|
| Furans | 1 | 2015 | 198 | 0.430 |
Why?
|
| Bone Marrow | 4 | 2016 | 2921 | 0.430 |
Why?
|
| Carbazoles | 1 | 2014 | 229 | 0.410 |
Why?
|
| Craniocerebral Trauma | 1 | 2016 | 494 | 0.390 |
Why?
|
| Blood Coagulation | 2 | 2014 | 1166 | 0.370 |
Why?
|
| Neurosurgery | 1 | 2016 | 683 | 0.340 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2024 | 3181 | 0.320 |
Why?
|
| Quinolines | 1 | 2015 | 769 | 0.320 |
Why?
|
| Neurology | 1 | 2016 | 785 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 13 | 2018 | 22332 | 0.300 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 4274 | 0.290 |
Why?
|
| Adenocarcinoma | 1 | 2025 | 6364 | 0.280 |
Why?
|
| Lipopolysaccharides | 5 | 2016 | 2216 | 0.280 |
Why?
|
| Immunity, Innate | 2 | 2016 | 3081 | 0.270 |
Why?
|
| Atrophy | 3 | 2016 | 1635 | 0.250 |
Why?
|
| Prostatic Neoplasms | 3 | 2023 | 11083 | 0.250 |
Why?
|
| Patient Care Team | 1 | 2016 | 2517 | 0.240 |
Why?
|
| Giant Cells | 1 | 2024 | 187 | 0.220 |
Why?
|
| Random Allocation | 4 | 2016 | 2395 | 0.220 |
Why?
|
| Retroperitoneal Space | 1 | 2023 | 173 | 0.200 |
Why?
|
| BK Virus | 1 | 2023 | 121 | 0.200 |
Why?
|
| Thrombelastography | 2 | 2014 | 193 | 0.190 |
Why?
|
| Nephritis, Interstitial | 1 | 2023 | 158 | 0.190 |
Why?
|
| Acute Lung Injury | 3 | 2018 | 377 | 0.190 |
Why?
|
| Shock, Hemorrhagic | 2 | 2015 | 225 | 0.190 |
Why?
|
| Spinal Injuries | 1 | 2015 | 301 | 0.190 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 194 | 0.180 |
Why?
|
| Disease Models, Animal | 9 | 2016 | 18293 | 0.180 |
Why?
|
| Tumor Virus Infections | 1 | 2023 | 440 | 0.170 |
Why?
|
| Mutation | 1 | 2025 | 30198 | 0.170 |
Why?
|
| Thymus Gland | 2 | 2016 | 1261 | 0.170 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 614 | 0.170 |
Why?
|
| Gastric Mucosa | 1 | 2023 | 602 | 0.170 |
Why?
|
| Urethra | 1 | 2022 | 406 | 0.170 |
Why?
|
| Respiratory Mucosa | 1 | 2023 | 438 | 0.170 |
Why?
|
| Mucins | 1 | 2022 | 567 | 0.160 |
Why?
|
| Physical Examination | 1 | 2015 | 1266 | 0.150 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2015 | 807 | 0.150 |
Why?
|
| Punctures | 2 | 2018 | 373 | 0.150 |
Why?
|
| Male | 21 | 2025 | 363698 | 0.150 |
Why?
|
| Prostate | 2 | 2023 | 1755 | 0.140 |
Why?
|
| Injections, Intraperitoneal | 2 | 2015 | 413 | 0.140 |
Why?
|
| beta Catenin | 1 | 2022 | 1043 | 0.140 |
Why?
|
| Hospitalization | 1 | 2016 | 10808 | 0.130 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2023 | 790 | 0.130 |
Why?
|
| Glasgow Outcome Scale | 1 | 2016 | 102 | 0.130 |
Why?
|
| Animals | 17 | 2023 | 168764 | 0.130 |
Why?
|
| Trauma Centers | 2 | 2016 | 952 | 0.130 |
Why?
|
| Cecum | 1 | 2016 | 232 | 0.130 |
Why?
|
| Macrophages | 4 | 2018 | 5772 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2024 | 2867 | 0.130 |
Why?
|
| Mice | 13 | 2023 | 81819 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2014 | 4348 | 0.120 |
Why?
|
| Interleukin-6 | 3 | 2014 | 3222 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 1873 | 0.120 |
Why?
|
| Abdominal Injuries | 1 | 2018 | 363 | 0.120 |
Why?
|
| Ligation | 1 | 2016 | 444 | 0.120 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 2003 | 0.120 |
Why?
|
| Glasgow Coma Scale | 1 | 2016 | 575 | 0.120 |
Why?
|
| Cytokines | 4 | 2016 | 7421 | 0.110 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2014 | 185 | 0.110 |
Why?
|
| Peritonitis | 1 | 2016 | 369 | 0.110 |
Why?
|
| Corticosterone | 1 | 2014 | 301 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2022 | 2464 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 3655 | 0.100 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2013 | 116 | 0.100 |
Why?
|
| Hematocrit | 1 | 2014 | 621 | 0.100 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 390 | 0.100 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2014 | 616 | 0.100 |
Why?
|
| Spleen | 2 | 2018 | 2296 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2013 | 582 | 0.100 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 790 | 0.090 |
Why?
|
| Aged | 7 | 2025 | 171117 | 0.090 |
Why?
|
| Fibrin | 1 | 2014 | 513 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2015 | 18973 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 59489 | 0.090 |
Why?
|
| Platelet Count | 1 | 2014 | 782 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 2176 | 0.090 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 349 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3529 | 0.090 |
Why?
|
| Valproic Acid | 1 | 2013 | 445 | 0.090 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 583 | 0.080 |
Why?
|
| Vacuum Curettage | 1 | 2009 | 44 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1333 | 0.080 |
Why?
|
| Hysteroscopy | 1 | 2009 | 63 | 0.080 |
Why?
|
| Leiomyomatosis | 1 | 2009 | 69 | 0.080 |
Why?
|
| Benzamides | 1 | 2015 | 1377 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2023 | 4424 | 0.080 |
Why?
|
| Uterine Diseases | 1 | 2009 | 108 | 0.080 |
Why?
|
| Tibia | 1 | 2014 | 1062 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 11022 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 586 | 0.080 |
Why?
|
| Resuscitation | 1 | 2013 | 679 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2016 | 5881 | 0.070 |
Why?
|
| Survival Rate | 3 | 2018 | 12795 | 0.070 |
Why?
|
| Femur | 1 | 2014 | 1310 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 4270 | 0.070 |
Why?
|
| Polyps | 1 | 2009 | 200 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2014 | 1530 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 12976 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1402 | 0.070 |
Why?
|
| Epigenomics | 1 | 2012 | 959 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 3807 | 0.070 |
Why?
|
| Female | 7 | 2025 | 396112 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2024 | 81514 | 0.060 |
Why?
|
| Humans | 12 | 2025 | 765968 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2016 | 10070 | 0.060 |
Why?
|
| Prognosis | 1 | 2024 | 29922 | 0.050 |
Why?
|
| Histones | 1 | 2014 | 2584 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2014 | 2464 | 0.050 |
Why?
|
| Middle Aged | 5 | 2025 | 223009 | 0.050 |
Why?
|
| Adult | 5 | 2025 | 223044 | 0.050 |
Why?
|
| Neutrophils | 1 | 2016 | 3776 | 0.050 |
Why?
|
| Pyridines | 1 | 2015 | 2888 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 1808 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2015 | 5020 | 0.050 |
Why?
|
| Virus Integration | 1 | 2023 | 304 | 0.050 |
Why?
|
| Phagocytosis | 2 | 2018 | 1520 | 0.050 |
Why?
|
| Liver | 1 | 2016 | 7562 | 0.040 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 1421 | 0.040 |
Why?
|
| Adolescent | 2 | 2023 | 88835 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 800 | 0.040 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2018 | 113 | 0.040 |
Why?
|
| Apoptosis | 1 | 2014 | 9514 | 0.040 |
Why?
|
| Surgical Stapling | 1 | 2018 | 99 | 0.040 |
Why?
|
| Pancreatic Fistula | 1 | 2018 | 148 | 0.040 |
Why?
|
| Inflammation | 1 | 2016 | 10850 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 1153 | 0.030 |
Why?
|
| Pancreatic Ducts | 1 | 2018 | 332 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2023 | 950 | 0.030 |
Why?
|
| Sutures | 1 | 2018 | 284 | 0.030 |
Why?
|
| Wounds, Penetrating | 1 | 2018 | 317 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 36532 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2018 | 1050 | 0.030 |
Why?
|
| Citrulline | 1 | 2014 | 106 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2015 | 251 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2018 | 820 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2014 | 364 | 0.030 |
Why?
|
| Hydrolases | 1 | 2014 | 146 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2013 | 46 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 3715 | 0.030 |
Why?
|
| Drainage | 1 | 2018 | 1179 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2012 | 75 | 0.020 |
Why?
|
| Colorimetry | 1 | 2012 | 148 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 431 | 0.020 |
Why?
|
| C-Reactive Protein | 2 | 2013 | 3850 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 512 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3819 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 14652 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 422 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7202 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 647 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 23601 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1749 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 2010 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2012 | 2485 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6309 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2143 | 0.010 |
Why?
|
| RNA | 1 | 2012 | 2717 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 8102 | 0.010 |
Why?
|
| Base Sequence | 1 | 2012 | 12403 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2015 | 54802 | 0.010 |
Why?
|
| Lung | 1 | 2018 | 10033 | 0.010 |
Why?
|
| Gene Expression | 1 | 2012 | 7584 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4392 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 7599 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 74840 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12768 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 23707 | 0.010 |
Why?
|
| United States | 1 | 2015 | 72903 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20659 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16721 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 65188 | 0.000 |
Why?
|
| Young Adult | 1 | 2009 | 59889 | 0.000 |
Why?
|
Concepts
(191)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_